Randomized trials demonstrate improvements in blood pressure and albuminuria in chronic kidney disease, suggesting ASIs offer safety benefits.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mazzieri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: